enVVeno Medical Corporation
NVNO | NASDAQ
$9.05
+$0.08 (+0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$9.05
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $148.11K
Enterprise Value $-20.83M
Beta 1.07
Average Volume 15.5K
Shares Outstanding (Diluted) 671K
Shares Change YoY 3938.76%
Institutional Ownership 15.37%
Exchange NASDAQ
ISIN US29415J2050
Price Performance
Price Change 1M -10.8%
Price Change 3M -7.6%
Price Change 6M -17.6%
Price Change YTD -27.2%
Price Change 1Y -72.4%
Price Change 3Y -95.0%
Price Change 5Y -97.4%
1M CAGR (ann.) -11.5%
1Y CAGR (ann.) -71.8%
5Y CAGR (ann.) -50.7%
All-Time CAGR -52.9%
Valuation
PE Ratio -0.02
Forward PE N/A
PEG Ratio -0.00
Forward PEG 0.00
PS Ratio N/A
Forward PS 0.00
PB Ratio 0.01
P/FCF Ratio -0.01
P/Adj. FCF Ratio -0.01
P/OCF Ratio -0.42
EV/Sales N/A
EV/EBIT 1.31
EV/EBITDA 1.34
EV/FCF 1.42
Earnings Yield -5746.7%
FCF Yield -9790.3%
Adj. FCF Yield -11256.0%
Financial Health
Net Cash $21.49M
Total Debt $505K
Cash & Short-Term Investments $21.49M
Total Assets $22.66M
Current Ratio 11.70
Quick Ratio 11.70
Debt / Equity Ratio 0.02
Debt / EBITDA -0.03
Debt / FCF -0.03
OCF / Debt -28.95
Interest Coverage 0.00
Altman Z-Score -12.25
Piotroski F-Score 1
Margins & Profitability
Gross Profit Margin 0.0%
Operating Profit Margin 0.0%
EBITDA Margin 0.0%
Net Profit Margin 0.0%
FCF Margin N/A
Adj. FCF Margin N/A
SBC / Revenue 0.0%
SBC Impact (per share) -15.0%
Returns
Return on Assets -69.4%
Return on Equity -62.3%
Return on Invested Capital -79.1%
Return on Capital Employed -80.7%
Return on Tangible Assets -69.4%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y -49.4%
EPS CAGR 3Y 51.1%
EPS CAGR 5Y 30.2%
EPS CAGR 10Y 33.4%
FCF CAGR 3Y 6.3%
FCF CAGR 5Y -1.6%
FCF CAGR 10Y -14.9%
Analyst Forecasts
Analyst Rating Hold
Analyst Count 0
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date N/A
EPS Estimate (next Q) N/A
EPS Growth Est (next Q) N/A
Revenue Est (next Q) N/A
Revenue Growth Est (next Q) N/A
Cash Flow
Operating Cash Flow $-14.62M
Free Cash Flow $-14.62M
Adj. Free Cash Flow $-16.81M
FCF Per Share -$21.79
OCF Per Share -$21.79
OCF/S Ratio 0.0%
Income Statement
Revenue $0
Gross Profit $-237K
Operating Income $-16.75M
EBITDA $-15.58M
Net Income $-15.72M
EPS (Diluted) -$520.08
Revenue / Employee N/A
Profit / Employee $-476.48K
Employees 33
Add to Watchlist
Select watchlists to add or remove NVNO